Security key
71722W107
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)
CUSIP: 71722W107
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 78,837,943
- Total 13F shares
- 72,636,064
- Share change
- +13,869,183
- Total reported value
- $1,312,668,227
- Put/Call ratio
- 75%
- Price per share
- $18.08
- Number of holders
- 133
- Value change
- +$264,199,549
- Number of buys
- 83
- Number of sells
- 28
Report period
Q3 2024
Institutions
133
Top holders
10
PHAT full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Phathom Pharmaceuticals, Inc. SEC filings
Phathom Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71722W107
Recent filing periods:
Top shareholders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
13%
|
10,109,279
|
$104,125,574 | — | 30 Jun 2024 | |
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
|
Company · 10%+ Owner |
9.5%
|
7,464,572
|
$76,885,092 | — | 30 Jun 2024 | |
| Carlyle Group Inc. |
13F
|
Company |
4.4%
|
3,496,808
|
$35,842,282 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
4%
|
3,143,452
|
$32,377,556 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.7%
|
2,926,373
|
$30,141,642 | — | 30 Jun 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
3.5%
|
2,757,579
|
$28,403,063 | — | 30 Jun 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
2.8%
|
2,244,828
|
$23,121,729 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
2,211,755
|
$22,781,077 | — | 30 Jun 2024 | |
| NEA Management Company, LLC |
13F
|
Company |
2.5%
|
1,960,169
|
$20,189,741 | — | 30 Jun 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
2.1%
|
1,620,000
|
$16,686,000 | — | 30 Jun 2024 | |
| TAKEDA PHARMACEUTICAL CO LTD |
3/4/5
13F
|
10%+ Owner · Company |
2%
from 13F
|
3,755,583
|
$30,420,222 | — | 24 Jan 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
1.9%
|
1,472,259
|
$15,164,268 | — | 30 Jun 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.8%
|
1,400,000
|
$14,420,000 | — | 30 Jun 2024 | |
| Portolan Capital Management, LLC |
13F
|
Company |
1.4%
|
1,130,089
|
$11,639,917 | — | 30 Jun 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
1.1%
|
875,000
|
$9,012,500 | — | 30 Jun 2024 | |
| Propel Bio Management, LLC |
13F
|
Company |
1.1%
|
869,927
|
$8,960,248 | — | 30 Jun 2024 | |
| Decheng Capital LLC |
13F
|
Company |
1.1%
|
850,000
|
$8,755,000 | — | 30 Jun 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
830,906
|
$8,558,332 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
806,047
|
$8,303,625 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
1%
|
785,990
|
$8,095,697 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
785,249
|
$8,088,065 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.97%
|
762,597
|
$7,854,749 | — | 30 Jun 2024 | |
| Catalys Pacific, LLC |
13F
|
Company |
0.92%
|
721,962
|
$7,436,208 | — | 30 Jun 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.76%
|
600,443
|
$6,185,000 | — | 30 Jun 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.76%
|
600,000
|
$6,180,000 | — | 30 Jun 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.75%
|
593,306
|
$6,111,052 | — | 30 Jun 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.66%
|
521,935
|
$5,375,930 | — | 30 Jun 2024 | |
| StepStone Group LP |
13F
|
Company |
0.54%
|
422,085
|
$4,347,476 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.53%
|
417,284
|
$4,298,025 | — | 30 Jun 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.46%
|
361,463
|
$3,907,415 | — | 30 Jun 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.45%
|
352,340
|
$3,629,102 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.38%
|
303,431
|
$3,125,339 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.36%
|
285,870
|
$2,944,461 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.35%
|
276,660
|
$2,849,598 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.29%
|
226,641
|
$2,334,402 | — | 30 Jun 2024 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.29%
|
225,000
|
$2,317,500 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.21%
|
168,323
|
$1,733,726 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.18%
|
141,022
|
$1,452,527 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.17%
|
134,357
|
$1,383,877 | — | 30 Jun 2024 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.15%
|
120,000
|
$1,236,000 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
114,721
|
$1,181,630 | — | 30 Jun 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.14%
|
113,592
|
$1,169,998 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.14%
|
112,691
|
$1,160,718 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
98,032
|
$1,009,730 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.12%
|
93,154
|
$959,488 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.1%
|
78,816
|
$811,805 | — | 30 Jun 2024 | |
| Penn Mutual Asset Management |
13F
|
Company |
0.08%
|
62,802
|
$646,861 | — | 30 Jun 2024 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
56,000
|
$576,800 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.07%
|
55,848
|
$575,235 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
55,178
|
$568,328 | — | 30 Jun 2024 |
Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) as of Q3 2024
As of 30 Sep 2024,
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,636,064 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, JENNISON ASSOCIATES LLC, Invesco Ltd., Carlyle Group Inc., BlackRock, Inc., VANGUARD GROUP INC, Ensign Peak Advisors, Inc, Woodline Partners LP, and NEA Management Company, LLC.
This page lists
133
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
113
Q3 2024 holders
133
Holder diff
20
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.